Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abnormalities, Drug-Induced | 26 | 2022 | 320 | 5.070 |
Why?
|
Limb Deformities, Congenital | 10 | 2022 | 136 | 4.180 |
Why?
|
Anticonvulsants | 28 | 2023 | 1907 | 3.650 |
Why?
|
Polydactyly | 6 | 2023 | 57 | 3.280 |
Why?
|
Congenital Abnormalities | 13 | 2019 | 708 | 3.180 |
Why?
|
Abnormalities, Multiple | 13 | 2022 | 1405 | 3.000 |
Why?
|
Teratogens | 12 | 2021 | 113 | 2.570 |
Why?
|
Amniotic Band Syndrome | 4 | 2022 | 22 | 2.360 |
Why?
|
Phenytoin | 9 | 2023 | 198 | 1.960 |
Why?
|
Toes | 6 | 2022 | 208 | 1.710 |
Why?
|
Fingers | 10 | 2022 | 511 | 1.650 |
Why?
|
Prenatal Exposure Delayed Effects | 12 | 2017 | 2393 | 1.490 |
Why?
|
Pregnancy | 72 | 2023 | 29002 | 1.480 |
Why?
|
Hand Deformities, Congenital | 3 | 2022 | 144 | 1.470 |
Why?
|
Registries | 18 | 2023 | 8039 | 1.310 |
Why?
|
Epilepsy | 17 | 2023 | 3289 | 1.260 |
Why?
|
Chorionic Villi Sampling | 4 | 2014 | 32 | 1.140 |
Why?
|
Valproic Acid | 6 | 2023 | 444 | 1.130 |
Why?
|
Prenatal Diagnosis | 9 | 2018 | 1227 | 1.080 |
Why?
|
Hypospadias | 2 | 2017 | 83 | 1.070 |
Why?
|
Fetus | 9 | 2022 | 1877 | 1.070 |
Why?
|
Infant, Newborn | 43 | 2022 | 25470 | 1.040 |
Why?
|
Phenobarbital | 7 | 2023 | 190 | 1.020 |
Why?
|
Chromosome Aberrations | 5 | 2018 | 1812 | 0.950 |
Why?
|
Pallister-Hall Syndrome | 1 | 2023 | 4 | 0.950 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2023 | 91 | 0.890 |
Why?
|
Teratology | 2 | 2020 | 8 | 0.870 |
Why?
|
Syndactyly | 2 | 2022 | 72 | 0.850 |
Why?
|
Hypothalamic Diseases | 2 | 2023 | 135 | 0.850 |
Why?
|
Finger Phalanges | 1 | 2022 | 38 | 0.850 |
Why?
|
Maternal Exposure | 8 | 2018 | 952 | 0.840 |
Why?
|
Hamartoma | 2 | 2023 | 236 | 0.810 |
Why?
|
Anencephaly | 2 | 2018 | 20 | 0.800 |
Why?
|
Hip Dislocation, Congenital | 2 | 2014 | 224 | 0.770 |
Why?
|
Abortion, Spontaneous | 3 | 2023 | 526 | 0.760 |
Why?
|
Carbamazepine | 6 | 2023 | 229 | 0.720 |
Why?
|
Pregnancy Complications | 14 | 2022 | 2867 | 0.680 |
Why?
|
Neural Tube Defects | 2 | 2019 | 253 | 0.680 |
Why?
|
Foot Deformities, Congenital | 2 | 2018 | 58 | 0.680 |
Why?
|
Face | 4 | 2021 | 985 | 0.640 |
Why?
|
Foramen Magnum | 1 | 2018 | 36 | 0.630 |
Why?
|
Double Outlet Right Ventricle | 1 | 2018 | 58 | 0.620 |
Why?
|
Ectromelia | 2 | 2009 | 30 | 0.620 |
Why?
|
Pregnancy in Diabetics | 2 | 2018 | 180 | 0.610 |
Why?
|
Genes, X-Linked | 1 | 2018 | 127 | 0.600 |
Why?
|
Triazines | 3 | 2016 | 316 | 0.570 |
Why?
|
Abortion, Eugenic | 1 | 2016 | 41 | 0.560 |
Why?
|
Triploidy | 1 | 2016 | 3 | 0.560 |
Why?
|
General Adaptation Syndrome | 1 | 2016 | 6 | 0.560 |
Why?
|
Stillbirth | 2 | 2019 | 346 | 0.540 |
Why?
|
Female | 85 | 2023 | 378853 | 0.530 |
Why?
|
Urethra | 1 | 2017 | 401 | 0.520 |
Why?
|
Genes, Recessive | 1 | 2018 | 650 | 0.510 |
Why?
|
Physical Examination | 1 | 2021 | 1231 | 0.500 |
Why?
|
Genes, Dominant | 2 | 2009 | 883 | 0.500 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1528 | 0.480 |
Why?
|
Anti-Retroviral Agents | 3 | 2019 | 1734 | 0.480 |
Why?
|
Clubfoot | 1 | 2014 | 63 | 0.480 |
Why?
|
Fructose | 2 | 2014 | 287 | 0.470 |
Why?
|
Fetal Growth Retardation | 2 | 2017 | 570 | 0.470 |
Why?
|
Delayed Diagnosis | 1 | 2017 | 429 | 0.470 |
Why?
|
Penis | 1 | 2014 | 207 | 0.470 |
Why?
|
Heterocyclic Compounds, 3-Ring | 3 | 2021 | 217 | 0.460 |
Why?
|
Neck | 1 | 2018 | 691 | 0.450 |
Why?
|
Hydatidiform Mole | 1 | 2016 | 279 | 0.450 |
Why?
|
Infant | 16 | 2023 | 34923 | 0.450 |
Why?
|
Birth Weight | 3 | 2017 | 2062 | 0.440 |
Why?
|
Anus, Imperforate | 1 | 2013 | 66 | 0.440 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2015 | 485 | 0.430 |
Why?
|
Vascular Malformations | 1 | 2018 | 442 | 0.420 |
Why?
|
Ectodermal Dysplasia | 1 | 2013 | 102 | 0.420 |
Why?
|
Pubic Bone | 1 | 2011 | 29 | 0.420 |
Why?
|
Humans | 93 | 2023 | 739398 | 0.400 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2012 | 143 | 0.400 |
Why?
|
Maternal Age | 1 | 2014 | 803 | 0.400 |
Why?
|
Cervical Vertebrae | 1 | 2018 | 972 | 0.390 |
Why?
|
Placenta | 2 | 2017 | 1682 | 0.390 |
Why?
|
Pregnancy Outcome | 8 | 2021 | 2789 | 0.390 |
Why?
|
Amines | 1 | 2012 | 277 | 0.380 |
Why?
|
Pancreatic Diseases | 1 | 2013 | 350 | 0.380 |
Why?
|
Misoprostol | 3 | 2020 | 95 | 0.370 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1253 | 0.360 |
Why?
|
Lasers | 1 | 2014 | 945 | 0.360 |
Why?
|
Growth Disorders | 2 | 2013 | 644 | 0.350 |
Why?
|
Nose | 1 | 2013 | 499 | 0.340 |
Why?
|
Encephalocele | 2 | 2018 | 138 | 0.340 |
Why?
|
Thalidomide | 3 | 2020 | 878 | 0.340 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2018 | 1896 | 0.340 |
Why?
|
Urogenital Abnormalities | 1 | 2011 | 252 | 0.330 |
Why?
|
Bone Regeneration | 1 | 2012 | 422 | 0.330 |
Why?
|
Societies, Medical | 1 | 2020 | 3739 | 0.320 |
Why?
|
International Classification of Diseases | 2 | 2021 | 867 | 0.320 |
Why?
|
Hand | 3 | 2021 | 875 | 0.310 |
Why?
|
Autistic Disorder | 1 | 2017 | 1164 | 0.310 |
Why?
|
Hypothyroidism | 1 | 2013 | 659 | 0.310 |
Why?
|
Genes, Homeobox | 1 | 2009 | 287 | 0.310 |
Why?
|
Pelvis | 1 | 2011 | 718 | 0.300 |
Why?
|
Heart Defects, Congenital | 3 | 2021 | 4546 | 0.300 |
Why?
|
Developmental Disabilities | 1 | 2016 | 1445 | 0.300 |
Why?
|
Facies | 2 | 2005 | 195 | 0.290 |
Why?
|
Mexican Americans | 1 | 2007 | 165 | 0.290 |
Why?
|
Cleft Palate | 1 | 2012 | 556 | 0.290 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2013 | 767 | 0.280 |
Why?
|
Kidney Diseases | 1 | 2018 | 2140 | 0.280 |
Why?
|
Mortality | 1 | 2018 | 2851 | 0.280 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1511 | 0.280 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2012 | 1127 | 0.270 |
Why?
|
Vascular Diseases | 1 | 2014 | 1152 | 0.270 |
Why?
|
Pregnancy Trimester, First | 4 | 2017 | 847 | 0.270 |
Why?
|
Tretinoin | 1 | 2009 | 513 | 0.270 |
Why?
|
Virilism | 1 | 2005 | 31 | 0.260 |
Why?
|
Phenotype | 7 | 2021 | 16301 | 0.260 |
Why?
|
HIV Infections | 6 | 2021 | 16764 | 0.260 |
Why?
|
Metacarpophalangeal Joint | 2 | 2018 | 82 | 0.250 |
Why?
|
Neurology | 1 | 2013 | 762 | 0.250 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 2004 | 10 | 0.250 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2005 | 245 | 0.250 |
Why?
|
Intelligence Tests | 2 | 2022 | 505 | 0.250 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2005 | 98 | 0.250 |
Why?
|
Oxazines | 3 | 2021 | 302 | 0.250 |
Why?
|
Hernia, Diaphragmatic | 1 | 2005 | 251 | 0.250 |
Why?
|
Child | 13 | 2023 | 77033 | 0.240 |
Why?
|
Gestational Age | 6 | 2021 | 3486 | 0.240 |
Why?
|
Duane Retraction Syndrome | 1 | 2004 | 60 | 0.230 |
Why?
|
Hemangioma | 1 | 2009 | 738 | 0.230 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3323 | 0.220 |
Why?
|
Prevalence | 9 | 2019 | 15153 | 0.220 |
Why?
|
Dermatoglyphics | 1 | 2002 | 21 | 0.220 |
Why?
|
Preimplantation Diagnosis | 1 | 2005 | 152 | 0.220 |
Why?
|
Substance Abuse, Intravenous | 1 | 2007 | 523 | 0.220 |
Why?
|
Hand Deformities | 1 | 2002 | 16 | 0.220 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2005 | 657 | 0.220 |
Why?
|
Alcohol Dehydrogenase | 1 | 2002 | 119 | 0.210 |
Why?
|
Neonatal Screening | 2 | 2017 | 591 | 0.210 |
Why?
|
Kidney | 1 | 2018 | 7144 | 0.210 |
Why?
|
Fetal Development | 2 | 2018 | 763 | 0.200 |
Why?
|
Vitamin K | 1 | 2004 | 291 | 0.200 |
Why?
|
Boston | 4 | 2018 | 9314 | 0.200 |
Why?
|
Antifibrinolytic Agents | 1 | 2004 | 251 | 0.200 |
Why?
|
Pyridones | 3 | 2021 | 707 | 0.200 |
Why?
|
North America | 2 | 2023 | 1249 | 0.190 |
Why?
|
Male | 33 | 2018 | 349022 | 0.190 |
Why?
|
Mesoderm | 1 | 2004 | 683 | 0.190 |
Why?
|
Thumb | 1 | 2002 | 227 | 0.190 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2021 | 2028 | 0.180 |
Why?
|
Autopsy | 1 | 2004 | 1004 | 0.180 |
Why?
|
Craniofacial Abnormalities | 2 | 2017 | 312 | 0.180 |
Why?
|
Ultrasonography | 3 | 2021 | 5941 | 0.170 |
Why?
|
Translocation, Genetic | 1 | 2005 | 1416 | 0.170 |
Why?
|
Cardiovascular Abnormalities | 1 | 2019 | 144 | 0.170 |
Why?
|
Hydranencephaly | 1 | 2018 | 5 | 0.160 |
Why?
|
Poland Syndrome | 1 | 2018 | 14 | 0.160 |
Why?
|
Child, Preschool | 8 | 2018 | 40802 | 0.160 |
Why?
|
Medical Records | 3 | 2012 | 1413 | 0.150 |
Why?
|
Massachusetts | 4 | 2017 | 8669 | 0.150 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3615 | 0.150 |
Why?
|
Hemoglobinopathies | 1 | 2018 | 96 | 0.150 |
Why?
|
Adult | 28 | 2021 | 213394 | 0.150 |
Why?
|
Metatarsal Bones | 1 | 2018 | 104 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2018 | 8791 | 0.140 |
Why?
|
Benzoxazines | 1 | 2018 | 306 | 0.140 |
Why?
|
Meningomyelocele | 1 | 2018 | 165 | 0.140 |
Why?
|
Mice, Inbred C3H | 2 | 2009 | 971 | 0.140 |
Why?
|
Consanguinity | 1 | 2018 | 456 | 0.140 |
Why?
|
Obstetric Labor, Premature | 1 | 2017 | 282 | 0.130 |
Why?
|
Adenine | 1 | 2021 | 940 | 0.130 |
Why?
|
Piperazines | 3 | 2021 | 2480 | 0.130 |
Why?
|
Ultrasonography, Prenatal | 4 | 2021 | 1689 | 0.130 |
Why?
|
Chorionic Gonadotropin | 1 | 2017 | 475 | 0.130 |
Why?
|
Cell Hypoxia | 1 | 2018 | 676 | 0.130 |
Why?
|
Zidovudine | 1 | 2017 | 623 | 0.130 |
Why?
|
Head and Neck Neoplasms | 1 | 2009 | 2706 | 0.130 |
Why?
|
Pedigree | 2 | 2018 | 4640 | 0.130 |
Why?
|
Incidental Findings | 1 | 2019 | 690 | 0.120 |
Why?
|
United States | 13 | 2022 | 69573 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1331 | 0.120 |
Why?
|
Foot | 1 | 2018 | 526 | 0.120 |
Why?
|
Cognition Disorders | 2 | 2007 | 4026 | 0.120 |
Why?
|
Reference Standards | 1 | 2018 | 1018 | 0.120 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2018 | 370 | 0.120 |
Why?
|
Karyotyping | 1 | 2016 | 1241 | 0.120 |
Why?
|
Cohort Studies | 7 | 2014 | 40389 | 0.120 |
Why?
|
Analysis of Variance | 2 | 2016 | 6370 | 0.120 |
Why?
|
Anti-HIV Agents | 2 | 2021 | 4320 | 0.110 |
Why?
|
Canada | 2 | 2011 | 2021 | 0.110 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 848 | 0.110 |
Why?
|
SEER Program | 1 | 2018 | 1506 | 0.110 |
Why?
|
Sex Distribution | 1 | 2018 | 2296 | 0.110 |
Why?
|
Risk | 5 | 2017 | 9684 | 0.110 |
Why?
|
Isoxazoles | 1 | 2014 | 216 | 0.110 |
Why?
|
Elbow | 1 | 2012 | 137 | 0.100 |
Why?
|
Cephalometry | 1 | 2013 | 381 | 0.100 |
Why?
|
Heart Failure | 1 | 2015 | 10793 | 0.100 |
Why?
|
Botswana | 3 | 2019 | 1034 | 0.100 |
Why?
|
Population Surveillance | 3 | 2019 | 2629 | 0.100 |
Why?
|
Hungary | 1 | 2010 | 84 | 0.090 |
Why?
|
Prenatal Care | 3 | 2012 | 1087 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2018 | 1356 | 0.090 |
Why?
|
Drug Therapy, Combination | 3 | 2021 | 6478 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2014 | 21694 | 0.090 |
Why?
|
Cartilage | 2 | 2012 | 819 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 2018 | 894 | 0.090 |
Why?
|
Forearm | 1 | 2012 | 407 | 0.090 |
Why?
|
Mouth Abnormalities | 1 | 2009 | 19 | 0.090 |
Why?
|
Smoking | 2 | 2018 | 8960 | 0.080 |
Why?
|
Bone and Bones | 3 | 2012 | 2575 | 0.080 |
Why?
|
Bone Development | 1 | 2012 | 483 | 0.080 |
Why?
|
Genotype | 1 | 2002 | 12951 | 0.080 |
Why?
|
Adolescent | 7 | 2018 | 85405 | 0.080 |
Why?
|
Transcription Factors | 2 | 2005 | 12120 | 0.080 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 474 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 1 | 2013 | 814 | 0.070 |
Why?
|
Lip | 1 | 2009 | 194 | 0.070 |
Why?
|
Maternal Health Services | 1 | 2012 | 452 | 0.070 |
Why?
|
Mice, Inbred AKR | 1 | 2006 | 107 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2391 | 0.070 |
Why?
|
Texas | 1 | 2007 | 394 | 0.070 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2007 | 322 | 0.070 |
Why?
|
Genetic Diseases, Inborn | 1 | 2011 | 588 | 0.070 |
Why?
|
Chromosomal Instability | 1 | 2007 | 183 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1776 | 0.070 |
Why?
|
Mouth | 1 | 2009 | 372 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10945 | 0.070 |
Why?
|
Preconception Care | 1 | 2006 | 135 | 0.060 |
Why?
|
Amniocentesis | 1 | 2005 | 116 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2017 | 76631 | 0.060 |
Why?
|
Nuchal Translucency Measurement | 1 | 2005 | 56 | 0.060 |
Why?
|
Odds Ratio | 2 | 2014 | 9846 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1420 | 0.060 |
Why?
|
Logistic Models | 4 | 2014 | 13402 | 0.060 |
Why?
|
Body Patterning | 1 | 2009 | 624 | 0.060 |
Why?
|
Clonazepam | 1 | 2004 | 137 | 0.060 |
Why?
|
Religion | 1 | 2007 | 357 | 0.060 |
Why?
|
Incidence | 2 | 2018 | 20913 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1534 | 0.060 |
Why?
|
Twins, Monozygotic | 1 | 2005 | 457 | 0.060 |
Why?
|
Reference Values | 1 | 2011 | 4983 | 0.060 |
Why?
|
Diseases in Twins | 1 | 2005 | 449 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1849 | 0.060 |
Why?
|
Review Literature as Topic | 1 | 2005 | 328 | 0.060 |
Why?
|
Syndrome | 3 | 2007 | 3241 | 0.060 |
Why?
|
Mutation | 2 | 2005 | 29658 | 0.060 |
Why?
|
Ear Canal | 1 | 2004 | 146 | 0.060 |
Why?
|
State Health Plans | 1 | 2005 | 218 | 0.060 |
Why?
|
Facial Asymmetry | 1 | 2004 | 170 | 0.060 |
Why?
|
Bone Diseases, Developmental | 1 | 2004 | 130 | 0.060 |
Why?
|
Hospitals, Urban | 1 | 2005 | 503 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1584 | 0.050 |
Why?
|
Prospective Studies | 5 | 2019 | 53037 | 0.050 |
Why?
|
Occipital Bone | 1 | 2002 | 54 | 0.050 |
Why?
|
Learning | 1 | 2012 | 1695 | 0.050 |
Why?
|
Cefuroxime | 1 | 2002 | 23 | 0.050 |
Why?
|
Linear Models | 1 | 2013 | 5948 | 0.050 |
Why?
|
Nova Scotia | 1 | 2022 | 34 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2742 | 0.050 |
Why?
|
Folic Acid Antagonists | 1 | 2002 | 82 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2014 | 2836 | 0.050 |
Why?
|
Fathers | 1 | 2004 | 357 | 0.050 |
Why?
|
Spine | 1 | 2009 | 1144 | 0.050 |
Why?
|
Dioxins | 1 | 2002 | 102 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2009 | 1548 | 0.050 |
Why?
|
National Health Programs | 1 | 2005 | 445 | 0.050 |
Why?
|
Age of Onset | 1 | 2008 | 3263 | 0.050 |
Why?
|
Genetic Counseling | 1 | 2005 | 601 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2014 | 3743 | 0.050 |
Why?
|
Siblings | 1 | 2005 | 853 | 0.050 |
Why?
|
Perception | 1 | 2007 | 1177 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2006 | 918 | 0.050 |
Why?
|
Alcohol Drinking | 2 | 2004 | 3945 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7726 | 0.050 |
Why?
|
Arm | 1 | 2003 | 585 | 0.050 |
Why?
|
Skull | 1 | 2004 | 809 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 21863 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2003 | 1585 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2409 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5702 | 0.040 |
Why?
|
Abortion, Induced | 1 | 2004 | 441 | 0.040 |
Why?
|
Intelligence | 1 | 2004 | 919 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 578 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2023 | 57650 | 0.040 |
Why?
|
Risk Factors | 6 | 2013 | 71974 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2009 | 2639 | 0.040 |
Why?
|
Heterozygote | 1 | 2005 | 2798 | 0.040 |
Why?
|
Microcephaly | 1 | 2002 | 429 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 23294 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2007 | 2040 | 0.040 |
Why?
|
Pediatrics | 1 | 2013 | 3454 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8431 | 0.040 |
Why?
|
Electroencephalography | 1 | 2013 | 6133 | 0.040 |
Why?
|
HIV Integrase Inhibitors | 1 | 2019 | 144 | 0.040 |
Why?
|
Alkynes | 1 | 2018 | 310 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2002 | 1364 | 0.040 |
Why?
|
Fertilization in Vitro | 1 | 2005 | 1283 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2006 | 19811 | 0.040 |
Why?
|
Observer Variation | 1 | 2003 | 2589 | 0.040 |
Why?
|
Hearing Loss | 1 | 2004 | 759 | 0.040 |
Why?
|
Cyclopropanes | 1 | 2018 | 421 | 0.040 |
Why?
|
Obesity | 1 | 2018 | 12643 | 0.030 |
Why?
|
Health Surveys | 1 | 2005 | 4022 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 2017 | 438 | 0.030 |
Why?
|
Cognition | 1 | 2012 | 6686 | 0.030 |
Why?
|
Ischemia | 1 | 2003 | 1908 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4539 | 0.030 |
Why?
|
Radiography | 2 | 2003 | 6998 | 0.030 |
Why?
|
Warfarin | 1 | 2002 | 1484 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 1833 | 0.030 |
Why?
|
Animals | 3 | 2011 | 168368 | 0.030 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 433 | 0.030 |
Why?
|
Young Adult | 5 | 2018 | 56255 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4463 | 0.030 |
Why?
|
Hospitals | 1 | 2005 | 3916 | 0.030 |
Why?
|
Alleles | 1 | 2002 | 6942 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12237 | 0.020 |
Why?
|
Mice | 2 | 2009 | 81002 | 0.020 |
Why?
|
Infant, Premature | 1 | 2017 | 2039 | 0.020 |
Why?
|
Chromosome Banding | 1 | 2007 | 278 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2010 | 38942 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9622 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1749 | 0.020 |
Why?
|
Education | 1 | 2010 | 543 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 24714 | 0.020 |
Why?
|
World Health Organization | 1 | 2012 | 1321 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 648 | 0.020 |
Why?
|
Dwarfism | 1 | 2007 | 145 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2002 | 4239 | 0.020 |
Why?
|
Isotretinoin | 1 | 2006 | 111 | 0.020 |
Why?
|
Hypertelorism | 1 | 2005 | 31 | 0.020 |
Why?
|
Epiglottis | 1 | 2005 | 79 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 1344 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3331 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 40050 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2005 | 581 | 0.010 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2005 | 502 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2006 | 533 | 0.010 |
Why?
|
Epiphyses | 1 | 2002 | 189 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2634 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 2003 | 732 | 0.010 |
Why?
|
Radius | 1 | 2003 | 422 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7690 | 0.010 |
Why?
|
Head | 1 | 2002 | 876 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4324 | 0.010 |
Why?
|
DNA | 1 | 2003 | 7275 | 0.010 |
Why?
|
Asthma | 1 | 2006 | 5950 | 0.000 |
Why?
|
Algorithms | 1 | 2003 | 13872 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 17384 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 212863 | 0.000 |
Why?
|